Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis c-positive recipients

American Journal of Transplantation

Volumn 10, Issue 11, 2010, Pages 2453-2462

  Morales, J M ^a   Campistol, J M ^b   Dominguez Gil B ^c   Andres A ^a   Esforzado, N ^b   Oppenheimer, F ^b   Castellano, G ^a   Fuertes, A ^a   Bruguera, M ^b   Praga, M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c ORGANIZACIÓN NACIONAL DE TRASPLANTES   (Spain)

Author keywords

Hepatitis C; kidney transplantation; liver disease; organ donation

Indexed keywords

ADULT; ARTICLE; CHRONIC LIVER DISEASE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SAFETY; TREATMENT OUTCOME;

ADULT; FEMALE; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY TRANSPLANTATION; LIVER DISEASES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TISSUE DONORS;

EID: 78349282310     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03280.x     Document Type: Article

References (34)

1. Pereira BJG, Milford EL, Kirkman RL, Levey AS,. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454 -460.
2. Roth D, Fernandez JA, Babischkin S, et al,. Detection of hepatitis C infection among organ donors: Evidence for low transmission of disease. Ann Intern Med 1992; 117: 470 -475.
3. Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C,. Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation 1993; 55: 674 -675.
4. Aeder MI, Shield CF, Tegtmeier GE, et al,. Incidence and clinical impact of hepatitis C virus (HCV) positive donors in cadaveric transplantation. Transplant Proc 1993; 25: 1469 -1471.
5. Tesi RJ, Waller K, Morgan CJ, et al,. Transmission of hepatitis C by kidney transplantation: The risks. Transplantation 1994; 57: 826 -831.
6. Morales JM, Campistol JM, Dominguez-Gil B,. Hepatitis C virus infection and kidney transplantation. Semin Nephrol 2002; 22: 365 -374.
7. Morales JM, Andres A, Campistol JM,. Hepatitis C virus and organ transplantation. N Engl J Med 1993; 328: 511 -512.
8. Morales JM, Campistol JM, Castellano G, et al,. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995; 47: 236 -240.
9. Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int 2008; 73 (Suppl 109): S1 -S99.
10. Covic A, Abramowicz D, Bruchfeld A, et al,. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: A European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009; 24: 719 -727.
11. Gordon CE, Balk EM, Becker BN, et al,. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation and treatment of hepatitis C in CKD. Am J Kid Dis 2008; 52: 811 -825.
12. Fabrizi F, Bunnapradist S, Lunghi G, Martin P,. Transplantation of kidneys from HCV-positive donors: A safe strategy J Nephrol 2003; 16: 617 -625.
13. Serón D, Arias M, Campistol JM, Morales JM,; Spanish Chronic Allograft Nephropathy Study Group. Late renal allograft failure between 1990 and 1998 in Spain: A changing scenario. Transplantation 2003; 76: 1588 -1594.
14. Morales JM, Campistol JM,. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000; 11: 1343 -1353.
15. Morales JM, Campistol JM, Andrés A, Rodicio JL,. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation. Curr Opin Nephrol Hypertens 1997; 6: 511 -515.
16. Ali MK, Light JA, Barhyte DY, et al,. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 1998; 66: 1694 -1697.
17. Mandal AK, Kraus ES, Samaniego M, et al,. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors. Clin Transplant 2000; 14:679 391 -396.
18. Woodside KJ, Ishihara K, Theisen JE, et al,. Use of kidneys from hepatitis C seropositive donors shortens waitlist time but does not alter one-yr outcome. Clin Transplant 2003; 17: 433 -437.
19. Veroux P, Veroux M, Puliatti C, et al,. Kidney transplantation from hepatitis C virus-positive donors into hepatitis C virus-positive recipients: A safe way to expand the donor Pool Transplant Proc 2005; 37: 2571 -1573.
20. Veroux P, Veroux M, Sparacino V, et al,. Kidney transplantation from donors with viral B and C hepatitis. Transplant Proc 2006; 38: 996 -998.
21. Kasprzyk T, Kwiatkowski A, Wszola M, et al,. Long-term results of kidney transplantation from HCV-positive donors. Transplant Proc 2007; 39: 2701 -2703.
22. Bucci JR, Matsumoto CS, Swanson SJ, et al,. Donor hepatitis C seropositivity: Clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation. J Am Soc Nephrol 2002; 13: 2974 -2982.
23. Abbott KC, Bucci JR, Matsumoto CS, et al,. Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003; 14: 2908 -2918.
24. Bucci JR, Lentine KL, Agodoa LY, Peters TG, Schnitzler MA, Abbott KC,. Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: Analysis of the USRDS/UNOS database. Clin Transpl 2004: 51 -61.
25. Abbott KC, Lentine KL, Bucci JR, Agodoa LY, Peters TG, Schnitzler MA,. The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant 2004; 4: 2032 -2037.
26. Luan FL, Schaubel DE, Zhang H, et al,. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation 2008; 85: 1601 -1606.
27. Mahmoud IM, Elhabashi AF, Elsawy E, El-Husseini AA, Sheha GE, Sobh MA,. The impact of hepatitis C virus viremia on renal graft and patient survival: A 9-year prospective study. Am J Kid Dis 2004; 43: 131 -139.
28. Forman JP, Tolkoff-Rubin N, Pascual M, Lin J,. Hepatitis C, acute humoral rejection and renal allograft survival. J Am Soc Nephrol 2004; 15: 3249 -3255.
29. Domínguez-Gil B, Esforzado N, Andrés A, et al,. Impact of biologics for induction in kidney transplant patients with a positive serology for hepatitis c: Long-term assessment in a collaborative study. Am Transplant Congr 2009 (abstract)
30. Testa G, Goldstein RM, Netto G, et al,. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 1998; 65: 925 -929.
31. Morales JM, Campistol JM, Andres A, et al,. Policies concerning the use of kidneys from donors infected with hepatitis C virus. Nephrol Dial Transplant 2000; 15: 71 -73.
32. Schussler T, Staffeld-Coit C, Eason J, Nair S,. Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant. Am J Transplant 2004; 4: 1375 -1378.
33. Natov SN, Lau JY, Ruthazer R, Schmid CH, Levey AS, Pereira BJ,; The New England Organ Bank Hepatitis C Study Group. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. Kidney Int 1999; 56: 700 -706.
34. Kamar N, Rostaing L, Selves J, et al,. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005; 5: 1704 -1712.